# US Bone Scan Market > US Bone Scan Market Research Report By Product (Radiopharmaceuticals, Imaging Devices) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.43% - **2024:** $ 9.5 Billion - **2025:** $ 10.02 Billion - **2035:** $ 17 Billion - **Key Players:** GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Holdings Corporation (JP), Medtronic (US), Hologic (US), Bracco Imaging (IT), Lantheus Medical Imaging (US) **Report ID:** MRFR/MED/17771-HCR · **Pages:** 100 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-bone-scan-market-19318 --- ## Market Summary ## **US Bone Scan Market Overview** As per MRFR analysis, the US Bone Scan Market Size was estimated at 7.65 (USD Billion) in 2023. The US Bone Scan Market Industry is expected to grow from 8(USD Billion) in 2024 to 9.5 (USD Billion) by 2035. The US Bone Scan Market CAGR (growth rate) is expected to be around 1.575% during the forecast period (2025 - 2035). ### **Key US Bone Scan Market Trends Highlighted** The US Bone Scan Market is witnessing several key trends driven by advancements in medical imaging technology and a growing aging population. As the prevalence of osteoporosis and bone-related diseases increases among older adults, the demand for bone scans is significantly rising. Enhanced imaging techniques, such as single-photon emission computed tomography (SPECT) and positron emission tomography-computed tomography (PET-CT), are becoming more common, providing improved diagnostic capabilities and precision in detecting bone disorders. Alongside technological progress, the increasing awareness of preventative health measures among consumers has resulted in more patients seeking early diagnosis and treatment options, further expanding the market. There are numerous opportunities to be explored within the market. For instance, the integration of artificial intelligence and machine learning into imaging systems presents a chance to streamline processes, increase accuracy, and reduce operational costs. Additionally, collaborations between healthcare providers and technology companies can foster innovations, leading to enhanced patient outcomes. The establishment of imaging centers in underserved areas could also help cater to a larger demographic, ensuring that more patients have access to necessary diagnostic procedures. Recent trends in the US show a shift towards value-based care, emphasizing patient outcomes and satisfaction rather than volume of services provided. This shift encourages healthcare providers to adopt advanced imaging technologies, as accurate and timely diagnosis can lead to better treatment plans and reduced healthcare costs in the long run. Additionally, public health initiatives aimed at educating the population about bone health are becoming more prominent, which will likely increase demand for bone scans as part of comprehensive health assessments. Overall, the future of the US Bone Scan Market appears promising, fueled by innovation and a commitment to improving patient care. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Bone Scan Market Drivers** ### **Increase in Bone-related Diseases** The rising incidence of bone-related diseases such as osteoporosis and arthritis is a significant driver for the US Bone Scan Market Industry. According to the National Osteoporosis Foundation, approximately 54 million Americans are affected by osteoporosis and low bone mass, with a particularly high prevalence in women aged 50 and older. This demographic is expected to continue growing due to the aging population, which the US Census Bureau projects will result in 83.7 million adults aged 65 and over by 2050. The increasing patient population requiring regular monitoring and diagnosis of bone-related ailments fuels demand for bone scans, emphasizing the critical role they play in preventive healthcare strategies. ### **Advancements in Imaging Technology** Technological advancements in imaging technology are propelling the growth of the US Bone Scan Market Industry. Enhanced imaging techniques, such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET), provide higher quality images that can lead to more accurate diagnoses. The American College of Radiology highlights that new imaging technologies have reduced radiation exposure while increasing the resolution of bone scans, leading to improved patient outcomes. As these technologies become more accessible in healthcare facilities across the US, the frequency of bone scans is expected to rise, driven by their increasing efficacy in detecting abnormalities. ### **Rising Geriatric Population** The growing geriatric population in the United States is a significant factor contributing to the growth of the US Bone Scan Market Industry. According to the Administration for Community Living, the number of adults aged 65 and older is anticipated to reach approximately 95 million by 2060, which emphasizes a larger demographic susceptible to bone disorders. As older adults are more likely to suffer from diseases affecting bone density and integrity, regular bone scanning becomes increasingly essential for timely diagnosis and management of these conditions. Consequently, healthcare providers are focusing on incorporating bone scans into routine assessments for this age group. ### **Increased Awareness and Preventive Healthcare** Growing awareness of bone health and preventive healthcare practices is another driving factor for the US Bone Scan Market Industry. Campaigns led by health organizations, including the National Institute of Arthritis and Musculoskeletal and Skin Diseases, promote the importance of early detection and management of bone health issues. With increasing education surrounding osteoporosis and its consequences, more individuals are seeking bone scans as part of their routine health checkups. This trend, combined with growing efforts to promote preventive healthcare strategies, suggests a robust demand for bone scans, as patients and healthcare professionals recognize their importance in maintaining bone health. ## **US Bone Scan Market Segment Insights** ### **Bone Scan Market Product Insights** The US Bone Scan Market is an integral part of the broader healthcare landscape, primarily focused on the diagnosis and management of bone-related conditions such as osteoporosis, fractures, and metastatic diseases. This market is distinctly categorized into various products, with Radiopharmaceuticals and Imaging Devices emerging as significant segments. In addition, Imaging Devices, which include advanced technologies such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET), enhance the capabilities of bone scanning procedures. The rise in technological innovations within Imaging Devices is transforming traditional practices and provides superior imaging quality, allowing for early detection and better management of bone-related disorders. The combination of these advancements in Radiopharmaceuticals and [Medical Digital Imaging Devices](../../../reports/medical-digital-imaging-devices-market-7880) not only enhances diagnostic accuracy but also leads to improved patient outcomes, positioning these segments as central to the evolving landscape of the US Bone Scan Market. With the continuous evolution of imaging technologies and radiopharmaceutical applications, both segments are set to capitalize on emerging opportunities and address the growing demand for effective bone health management solutions across the US. This focus on both accuracy in diagnostics and advanced imaging methodologies highlights the critical importance of these segments in responding to the healthcare needs of the population. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Bone Scan Market Key Players and Competitive Insights** The competitive landscape of the US Bone Scan Market is characterized by a dynamic array of companies that continually innovate and adapt to changing healthcare needs. This market focuses primarily on advanced imaging techniques utilized for evaluating bone health, diagnosing conditions such as osteoporosis, and detecting fractures. With increasing awareness regarding bone density health, a growing geriatric population, and rising incidences of bone-related disorders, the market exhibits substantial potential for growth. Companies in this sector are competing on multiple fronts including technological advancements, operational efficiencies, product differentiation, and strategic partnerships to enhance their presence and market share. The competitive insights reveal a landscape that emphasizes innovation, customer-centric approaches, and regulatory compliance as cornerstone strategies for success. Hologic has carved out a significant niche in the US Bone Scan Market thanks to its commitment to women's health and technological advancements in medical imaging. The company leverages its expertise in bone health assessment and employs state-of-the-art dual-energy x-ray absorptiometry (DXA) technology to provide precise and reliable evaluations of bone density. Hologic's strong brand reputation is bolstered by its extensive research and clinical validation, resulting in high-quality products that are widely accepted by healthcare providers. Furthermore, Hologic’s strong focus on education and support for healthcare professionals ensures that it remains a trusted partner in the market. The company’s strategic investments in innovation and its responsive approach to market demands enhance its competitive position within the bone scan sector. Baker Hughes, while primarily known for its oil and gas products, has made strategic investments in the healthcare sector, influencing the US Bone Scan Market with innovative solutions that leverage advanced imaging technologies. The company has diversified its service offerings to include equipment and support for bone health assessments, showcasing its commitment to addressing healthcare challenges. Baker Hughes employs a unique approach through the integration of its engineering expertise, thus creating high-quality imaging solutions that enhance diagnostic accuracy. The company's strong market presence is supported by its focus on collaborations and potential mergers that aim to expand its healthcare footprint. Moreover, Baker Hughes is committed to ongoing research and development, positioning itself favorably to leverage emerging technologies in the bone scan domain while maintaining a robust service network across the U.S. ### **Key Companies in the US Bone Scan Market Include** ### **US Bone Scan Market Industry Developments** Recent developments in the US Bone Scan Market have highlighted a focus on advanced imaging technologies and machine learning applications. Companies such as Siemens Healthineers and Hologic have been at the forefront, introducing innovative bone density scanning equipment that combines precise imaging with efficiency. The market has seen a positive growth trajectory, with an increased emphasis on early diagnosis of bone-related disorders. In October 2023, Siemens Healthineers made strides in expanding their offerings by announcing collaborations aimed at enhancing imaging software solutions, which may significantly improve diagnosis accuracy for conditions such as osteoporosis. Moreover, growth in market valuation for major players like Medtronic and Phillips Healthcare has been reported, bolstered by rising healthcare expenditures and an aging population in the US. In terms of mergers and acquisitions, Hologic acquired a diagnostic imaging company in September 2023 to bolster its portfolio, creating a ripple effect in competitive strategies within the market. The ongoing integration of Artificial Intelligence solutions into bone imaging is accelerating as well, with companies like CureMetrix making advancements that further optimize bone scan results, underscoring the dynamic landscape of the US Bone Scan Market. ## **US Bone Scan Market Segmentation Insights** ### **Bone Scan Market Product Outlook** ## Market Drivers ### Increased Healthcare Expenditure Rising healthcare expenditure in the US is a significant driver for the bone scan market. As healthcare budgets expand, there is a greater allocation of funds towards diagnostic imaging services. In 2025, healthcare spending in the US is expected to exceed $4 trillion, with a notable portion directed towards advanced imaging technologies. This trend indicates a growing recognition of the importance of early diagnosis and preventive care in managing bone health. The bone scan market stands to benefit from this increased investment, as healthcare providers are more likely to adopt advanced imaging techniques to enhance patient care. Consequently, the demand for bone scans is anticipated to rise, reflecting the broader trend of prioritizing health and wellness. ### Rising Incidence of Bone Disorders The increasing prevalence of bone disorders, such as osteoporosis and osteoarthritis, is a primary driver for the bone scan market. In the US, osteoporosis affects approximately 10 million individuals, with an additional 44 million at risk. This growing patient population necessitates advanced diagnostic tools, including bone scans, to monitor bone health and assess fracture risk. The bone scan market is likely to experience growth as healthcare providers seek effective methods for early detection and management of these conditions. Furthermore, the aging population, which is more susceptible to bone-related issues, contributes to the demand for bone scans. As the US population ages, the need for accurate diagnostic imaging becomes increasingly critical, thereby propelling the market forward. ### Technological Innovations in Imaging Technological advancements in imaging modalities are significantly influencing the bone scan market. Innovations such as hybrid imaging techniques, including PET/CT and SPECT/CT, enhance the accuracy and efficiency of bone scans. These technologies allow for better visualization of bone metabolism and pathology, leading to improved patient outcomes. The bone scan market is witnessing a shift towards more sophisticated imaging solutions, which are expected to capture a larger market share. In 2025, the market for advanced imaging technologies is projected to reach approximately $2 billion in the US. This growth is indicative of the increasing reliance on advanced diagnostic tools in clinical practice, further driving the demand for bone scans. ### Growing Demand for Preventive Healthcare The shift towards preventive healthcare is emerging as a crucial driver for the bone scan market. Patients and healthcare providers are increasingly recognizing the value of early detection and intervention in managing bone health. This trend is reflected in the rising number of routine screenings and diagnostic tests, including bone scans, aimed at identifying potential issues before they escalate. The bone scan market is likely to see a surge in demand as more individuals seek proactive measures to maintain their bone health. Additionally, public health campaigns promoting awareness of bone health are contributing to this trend, encouraging individuals to undergo regular screenings. As a result, the market for bone scans is expected to expand in response to this growing emphasis on preventive care. ### Regulatory Support for Advanced Diagnostics Regulatory support for advanced diagnostic technologies is playing a pivotal role in shaping the bone scan market. The US Food and Drug Administration (FDA) has been actively approving new imaging devices and techniques that enhance the accuracy and safety of bone scans. This regulatory environment fosters innovation and encourages manufacturers to develop cutting-edge solutions for bone health assessment. The bone scan market is likely to benefit from this supportive framework, as it facilitates the introduction of novel imaging technologies that meet stringent safety and efficacy standards. As regulatory bodies continue to endorse advanced diagnostics, the demand for bone scans is expected to rise, reflecting the ongoing commitment to improving patient outcomes through innovative imaging solutions. ## Future Outlook The [Bone Scan Market](https://www.marketresearchfuture.com/reports/bone-scan-market-5027) is projected to grow at a 5.43% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of bone disorders, and rising healthcare expenditure. **New opportunities:** - Development of AI-driven imaging analysis tools - Expansion of mobile bone scan units for remote diagnostics - Partnerships with telehealth platforms for integrated services By 2035, the bone scan market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Product: Radiopharmaceuticals (Largest) vs. Imaging Devices (Fastest-Growing) Within the US bone scan market, radiopharmaceuticals dominate the product segment, accounting for a significant share due to their essential role in facilitating accurate and effective diagnostic imaging. Imaging devices, while smaller in market share, are gaining traction thanks to advancements in technology and increasing adoption in clinical settings. Both segments are crucial, but their market presence varies significantly, with radiopharmaceuticals leading in demand. The growth trends for radiopharmaceuticals remain steady, supported by ongoing innovations and the expansion of related healthcare services. Conversely, imaging devices are experiencing the fastest growth driven by technological advancements such as enhanced imaging quality and faster scan times. Factors like an aging population seeking diagnostic imaging, along with increased awareness and funding for bone health, significantly contribute to the burgeoning growth of imaging devices. Radiopharmaceuticals (Dominant) vs. Imaging Devices (Emerging) Radiopharmaceuticals are characterized by their ability to offer targeted imaging that enables clinicians to detect bone disorders with high precision, making them a dominant force in the US bone scan market. Their established use in both diagnostic and therapeutic applications underlines their critical role. Imaging devices, on the other hand, represent the emerging aspect of this market, with rapid advancements leading to improved functionalities such as higher resolution images and faster scanning capabilities. As healthcare providers look to optimize patient outcomes, the push towards adopting state-of-the-art imaging devices reflects a shift in preferences, potentially reshaping market dynamics in the coming years. ### By Application: Fractures (Largest) vs. Cancer Originating in Bone (Fastest-Growing) The US bone scan market exhibits diverse applications with fractures commanding the largest share, reflecting their prevalence in the population. Arthritis also holds a substantial portion, characterized by its chronic nature leading to increased diagnostic scans. Paget's disease, although less common, contributes to the market alongside cancer originating in bone, which is steadily rising as awareness and diagnostic capabilities expand. Other conditions also play a role, albeit to a lesser extent, thereby showcasing a well-rounded distribution across the segment. Currently, the fastest-growing application within the US bone scan market is cancer originating in bone. This growth can be attributed to advancements in diagnostic technology and an increase in cancer incidence rates. Moreover, the aging population is leading to higher incidences of both cancer and related bone disorders. As healthcare providers enhance their focus on early detection and treatment,segments like fractures and arthritis remain significant but face competition from the emerging prominence of cancer diagnostics. Fractures (Dominant) vs. Cancer Originating in Bone (Emerging) Fractures represent the dominant segment in the US bone scan market, driven by the high incidence of bone-related injuries and the need for accurate diagnostics. This segment is characterized by a wide range of applications, including sports injuries and age-related fractures, making it essential for healthcare providers. On the other hand, cancer originating in bone is an emerging segment due to increased awareness and advancements in imaging technology. The integration of novel diagnostic methods caters to the growing need for early detection of bone cancers, positioning this segment for significant growth. Both segments demonstrate vital importance, yet they serve distinctly different medical needs and patient populations. ### By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing) In the US bone scan market, hospitals hold the largest market share, attributed to their comprehensive services and advanced imaging technologies. Clinics and diagnostic centers also play critical roles, yet they are comparatively smaller in market presence. However, the dynamics are changing as the demand for bone density assessments rises, indicating a gradual shift in market share distribution among these segments. The growth trends in the US bone scan market are predominantly driven by increasing awareness of bone health and the prevalence of osteoporosis, especially among the aging population. Clinics are emerging as the fastest-growing segment, as they offer accessible and quicker services for bone scanning, catering to a broader demographic. This shift reflects a growing preference for outpatient services over traditional hospital settings, spurred by technological advancements and a focus on patient-centered care. Hospitals (Dominant) vs. Clinics (Emerging) Hospitals are the dominant players in the US bone scan market, leveraging their vast resources, skilled personnel, and technological advancements to provide comprehensive diagnostic services. Their ability to offer a full spectrum of healthcare services, including in-depth analysis and follow-up treatments, positions them as the preferred choice for complex cases. In contrast, clinics are emerging as a key segment due to their convenience and focus on outpatient care. They attract patients with shorter wait times and lower costs, often promoting preventive care. This evolving landscape indicates a trend where clinics are increasingly expanding their services, making them competitive with traditional hospital offerings, particularly for routine bone density testing. ## Competitive Benchmarking The bone scan market exhibits a dynamic competitive landscape characterized by rapid technological advancements and a growing emphasis on precision medicine. Key players such as GE Healthcare (US), Siemens Healthineers (DE), and Lantheus Medical Imaging (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. GE Healthcare (US) focuses on integrating artificial intelligence (AI) into imaging technologies, which appears to streamline diagnostic processes and improve patient outcomes. Siemens Healthineers (DE) emphasizes regional expansion and digital transformation, aiming to enhance operational efficiencies and broaden its service offerings. Collectively, these strategies foster a competitive environment that prioritizes technological innovation and patient-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The competitive structure of the bone scan market is moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for diverse offerings and fosters innovation, as companies strive to differentiate themselves through unique value propositions. In October Lantheus Medical Imaging (US) announced a strategic partnership with a leading AI firm to develop advanced imaging algorithms aimed at improving the accuracy of bone scans. This collaboration is likely to enhance Lantheus's product portfolio and position it as a leader in the integration of AI within diagnostic imaging. The strategic importance of this partnership lies in its potential to significantly reduce diagnostic errors and improve patient care, thereby strengthening Lantheus's competitive edge. In September Siemens Healthineers (DE) launched a new line of portable bone scan devices designed for use in outpatient settings. This move reflects a growing trend towards decentralizing healthcare services, allowing for greater accessibility and convenience for patients. The introduction of these devices is expected to capture a larger market share by addressing the needs of healthcare providers seeking efficient and flexible imaging solutions. In August GE Healthcare (US) unveiled a new software platform that integrates imaging data with electronic health records (EHRs), facilitating seamless data sharing among healthcare providers. This innovation is indicative of the ongoing digital transformation within the industry, as it enhances interoperability and streamlines workflows. The strategic significance of this development lies in its potential to improve clinical decision-making and patient management, thereby reinforcing GE Healthcare's position in the market. As of November current competitive trends in the bone scan market are heavily influenced by digitalization, sustainability, and AI integration. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, innovative solutions, and reliable supply chains. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive advantage. ## Recent News & Developments Recent developments in the US Bone Scan Market have highlighted a focus on advanced imaging technologies and machine learning applications. Companies such as Siemens Healthineers and Hologic have been at the forefront, introducing innovative bone density scanning equipment that combines precise imaging with efficiency. The market has seen a positive growth trajectory, with an increased emphasis on early diagnosis of bone-related disorders. In October 2023, Siemens Healthineers made strides in expanding their offerings by announcing collaborations aimed at enhancing imaging software solutions, which may significantly improve diagnosis accuracy for conditions such as osteoporosis. Moreover, growth in market valuation for major players like Medtronic and Phillips Healthcare has been reported, bolstered by rising healthcare expenditures and an aging population in the US. In terms of mergers and acquisitions, Hologic acquired a diagnostic imaging company in September 2023 to bolster its portfolio, creating a ripple effect in competitive strategies within the market. The ongoing integration of Artificial Intelligence solutions into bone imaging is accelerating as well, with companies like CureMetrix making advancements that further optimize bone scan results, underscoring the dynamic landscape of the US Bone Scan Market. ## Report Scope | MARKET SIZE 2024 | 9.5(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 10.02(USD Billion) | | MARKET SIZE 2035 | 17.0(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.43% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Holdings Corporation (JP), Medtronic (US), Hologic (US), Bracco Imaging (IT), Lantheus Medical Imaging (US) | | Segments Covered | Product, Application, End User | | Key Market Opportunities | Advancements in imaging technology enhance diagnostic accuracy in the bone scan market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the bone scan market, enhancing diagnostic capabilities and patient outcomes. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the projected market valuation of the US bone scan market by 2035?** A: The projected market valuation of the US bone scan market is expected to reach $17.0 Billion by 2035. **Q: What was the market valuation of the US bone scan market in 2024?** A: The market valuation of the US bone scan market was $9.5 Billion in 2024. **Q: What is the expected CAGR for the US bone scan market during the forecast period 2025 - 2035?** A: The expected CAGR for the US bone scan market during the forecast period 2025 - 2035 is 5.43%. **Q: Which product segment is projected to have the highest valuation by 2035?** A: The Imaging Devices segment is projected to reach $8.75 Billion by 2035, surpassing the Radiopharmaceuticals segment. **Q: What are the key applications driving the US bone scan market?** A: Key applications include Fractures, Arthritis, and Cancer Originating in Bone, with Fractures projected to reach $5.1 Billion by 2035. **Q: Who are the leading players in the US bone scan market?** A: Leading players in the US bone scan market include GE Healthcare, Siemens Healthineers, and Philips Healthcare. **Q: What is the expected growth of the Fractures application segment by 2035?** A: The Fractures application segment is expected to grow to $5.1 Billion by 2035. **Q: How does the market for Diagnostic Centers compare to other end users?** A: The market for Diagnostic Centers is projected to reach $3.5 Billion by 2035, indicating substantial growth compared to other end users. **Q: What is the anticipated valuation of the Arthritis application segment by 2035?** A: The Arthritis application segment is anticipated to reach $3.6 Billion by 2035. **Q: What is the expected growth trajectory for the Others segment in the application category?** A: The Others segment in the application category is expected to grow to $3.5 Billion by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-bone-scan-market-19318*